Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | JAK2 | O60674 | 1/20 | 0.41 |
| ▸ | JAK3 | P52333 | 1/20 | 0.41 |
| ▸ | PTGES | O14684 | 1/20 | 0.35 |
| ▸ | CDK4 | P11802 | 1/20 | 0.35 |
| ▸ | CCND1 | P24385 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.34 |
| ▸ | AHR | P35869 | 1/20 | 0.34 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18314423 | 0.98 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMJAK2JAK3 | |
| SCHEMBL18088948 | 0.98 | L3MBTL1 (0.48) | L3MBTL1KDM4EATMJAK2JAK3 | |
| SCHEMBL19933767 | 0.97 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMJAK2JAK3 | |
| SCHEMBL17642158 | 0.97 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMJAK2JAK3 | |
| SCHEMBL19420258 | 0.97 | L3MBTL1 (0.47) | L3MBTL1KDM4EATMJAK2JAK3 | |
| SCHEMBL19829062 | 0.96 | L3MBTL1 (0.51) | L3MBTL1KDM4EATMJAK2JAK3 | |
| SCHEMBL19037064 | 0.94 | ATM (0.42) | L3MBTL1KDM4EATMJAK2JAK3 | |
| SCHEMBL16542835 | 0.94 | L3MBTL1 (0.53) | L3MBTL1KDM4EATMJAK2JAK3 | |
| SCHEMBL19132352 | 0.94 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMJAK2JAK3 | |
| SCHEMBL19266619 | 0.94 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMJAK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10749119-B2 | Plurality of host materials and organic electroluminescent device comprising the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD (KR) | 2020-08-18 | — | — | US | disclosed |
| US-20180033975-A1 | A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2018-02-01 | — | — | US | disclosed |
| US-20180033975-A1 | A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2018-02-01 | — | — | US | disclosed |
| WO-2016148390-A1 | A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2016-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10749119-B2 | Plurality of host materials and organic electroluminescent device comprising the same | SOD1, L3MBTL4, TELO2 | L3MBTL1 24/4885KDM4E 2303/4885ATM 1493/4885 |
| US-20180033975-A1 | A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | SOD1, TELO2, L3MBTL4 | L3MBTL1 14/4885KDM4E 2091/4885ATM 1846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.